Skip to content
10-K

Annual Report

Avant Diagnostics, Inc

0001493152-18-017043

← back to feed
Filed
Dec 4, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Oct 30, 2018 336.96M sh
Operating Cash Flow FY 2017 · Sep 30, 2016 −$683K
Current Liabilities FY 2017 · Sep 30, 2016 $2.12M
Total Liabilities FY 2017 · Sep 30, 2016 $2.12M
Current Assets FY 2017 · Sep 30, 2016 $42.23K
Total Assets FY 2017 · Sep 30, 2016 $5.68M
Sga Expense FY 2017 · Sep 30, 2016 $1.23M
Net Income FY 2017 · Sep 30, 2016 −$11.76M
Operating Income FY 2017 · Sep 30, 2016 −$11.56M
Gross Profit FY 2017 · Sep 30, 2016 $65.52K
Cost Of Revenue FY 2017 · Sep 30, 2016 $52.52K
Revenue FY 2017 · Sep 30, 2016 $118.04K
Cash And Equivalents FY 2017 · Sep 30, 2015 $43.64K
Stockholders Equity FY 2017 · Sep 30, 2015 $1.22M